Alpha 1-adrenoceptor subtypes in aorta (alpha 1A) and liver (alpha 1B)

Eur J Pharmacol. 1991 Mar 25;206(3):199-202. doi: 10.1016/s0922-4106(05)80019-7.

Abstract

The effect of several alpha 1 adrenoceptor antagonists on the alpha 1-adrenoceptor-mediated stimulation of phosphatidylinositol labeling was studied comparatively in rat hepatocytes and rabbit aorta. It was observed that 5-methyl urapidil and WB 4101 were much more potent in rabbit aorta than in hepatocytes. The orders of potency were prazosin much greater than 5-methyl urapidil greater than or equal to WB 4101 in liver cells and WB 4101 greater than or equal to 5 methyl urapidil = prazosin in aorta. Treatment with chlorethylclonidine inhibited 70-80% of the stimulation of labeling induced by epinephrine in rat liver, but only 30-40% of that in aorta. Our data suggest the existence of two pharmacologically distinct receptors in these tissues i.e.m alpha 1A-adrenoceptors in aorta and alpha 1B in liver cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Clonidine / analogs & derivatives
  • Clonidine / pharmacology
  • Dioxanes / pharmacology
  • Epinephrine / pharmacology
  • In Vitro Techniques
  • Liver / cytology
  • Liver / metabolism*
  • Membranes / drug effects
  • Membranes / metabolism
  • Muscle, Smooth, Vascular / metabolism*
  • Phosphatidylinositols / metabolism
  • Piperazines / pharmacology
  • Prazosin / pharmacology
  • Rabbits
  • Receptors, Adrenergic, alpha / metabolism*

Substances

  • Adrenergic alpha-Antagonists
  • Dioxanes
  • Phosphatidylinositols
  • Piperazines
  • Receptors, Adrenergic, alpha
  • 5-methylurapidil
  • chlorethylclonidine
  • (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
  • Clonidine
  • Prazosin
  • Epinephrine